NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ad Scientiam

Ad Scientiam

Private
ParisHealthcare & Life Scienceshttps://www.adscientiam.com/en

Last Round

VC Round

Nov 5, 2023

Company Overview

Ad Scientiam is a digital health company that develops and validates digital biomarkers for the continuous monitoring of severe and debilitating chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital biomarkersoftware medical deviceSaMDremote patient monitoringdigital healthRPMclinical trial technologyreal-world evidenceRWEneurology softwarepatient self-assessmenthealthtechclinical decision supportmHealthdigital phenotyping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ad Scientiam Comparables

Compare Ad Scientiam with similar companies based on industry and business-model similarity.

Ad Scientiam comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altoida, Inc.
87%
Koneksa Health
83%
Neurotrack Technologies, Inc.
78%

Ad Scientiam Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 5, 2023
VC RoundJul 13, 2017

Key People

Founding team and executive leadership

Matthieu Lamy

Chief Executive Officer

Executive Team

Ad Scientiam Investors

Notable investors and investment history

Ad Scientiam investors
InvestorRounds
TechLife CapitalVC Round
BpifranceVC Round

Ad Scientiam Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ad Scientiam Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ad Scientiam's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range59
Year Founded2013
Last FundingNov 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.